What Pharma Can Learn From Military Intelligence

Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence

August 21, 2026
6 min

The Medicine Maker

Overview

Tony Page discusses the parallels between military intelligence and pharmaceutical decision-making, emphasizing the need for structured approaches to market intelligence and decision cycles in the pharma industry.

Background

The integration of military intelligence strategies into the pharmaceutical sector can enhance decision-making processes. Effective intelligence management is crucial for navigating complex market dynamics and mitigating risks.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

Proactive intelligence processes are essential for supporting organizational strategy and tactics.
Companies often fail to recognize intelligence as a distinct management process with specific methods and frameworks.
Early warning intelligence is critical to avoid being blindsided by unforeseen challenges.
Decision cycle time in pharma should be dynamic, adapting to real-time information rather than following a static plan.
Intelligence must be actionable and trustworthy to facilitate timely decision-making.